Prebiotics: Concept, properties and beneficial effects;Prebióticos; Concepto, propiedades y efectos beneficiosos

Nutricion Hospitalaria

Volumn 31, Issue , 2015, Pages 99-118

  Corzo, N ^a   Alonso, J L ^b   Azpiroz, F ^c   Calvo, M A ^c   Cirici, M ^d   Leis, R ^e   Lombo F ^f   Mateos Aparicio, I ^g   Plou, F J ^h   Ruas Madiedo, P ⁱ   Ruperez P ^j   Redondo Cuenca, A ^g   Sanz, M L ^k   Clemente, A ^l  

^a INSTITUTE OF FOOD SCIENCE RESEARCH CIAL   (Spain)

^b UNIVERSITY OF VIGO   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^d BENEO Connecting nutrition and health BENEO Ibérica   (Spain)

^e Instituto de Salud Carlos III   (Spain)

^f DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

^g UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^h INSTITUTO DE CATÁLISIS Y PETROLEOQUÍMICA   (Spain)

ⁱ DEPARTMENT OF MICROBIOLOGY AND BIOCHEMISTRY OF DAIRY PRODUCTS   (Spain)

^j INSTITUTE OF FOOD SCIENCE   (Spain)

^k INSTITUTO DE QUÍMICA ORGÁNICA GENERAL   (Spain)

^l CSIC   (Spain)

more..

Author keywords

Analysis; Beneficial effects; Definitions; Models; Prebiotics

Indexed keywords

CARBOHYDRATE; PREBIOTIC AGENT;

DIETARY FIBER; GASTROINTESTINAL TRACT; HUMAN; INTESTINE FLORA; MICROBIOLOGY; MICROFLORA;

CARBOHYDRATES; DIETARY FIBER; GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL TRACT; HUMANS; MICROBIOTA; PREBIOTICS;

EID: 84923850797     PISSN: 02121611     EISSN: 16995198     Source Type: Journal    
DOI: 10.3305/nh.2015.31.sup1.8715     Document Type: Article

References (147)

1. Mohammadi R, Mortazavian AM. Tehcnological aspects of prebiotics in probiotic fermented milks Food Rev Int 2011; 27: 192-212.
2. Lamsal BP. Production, health aspects and potential food uses of dairy prebiotic galactooligosaccharides. J Sci Food Agric 2012; 92: 2020-2028.
3. Sako T, Matsumoto K, Tanaka R. Recent progress on research and applications of non-digestible galacto-oligosaccharides. Int Dairy J 1999; 9: 69-80.
4. Gibson GR., Roberfroid MB. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr 1995; 125:1401-1412.
5. Gibson GR, Probert HM, Loo JV, Rastall RA, Roberfroid MB. Dietary modulation of the human colonic microbiota: updating the concept of prebiotics. Nutr Res Rev 2004; 17: 259-275.
6. Roberfroid M, Gibson GR, Hoyles L, McCartney AL, Rastall RA, Rowland I, Wolvers D, Watzl B, Szajewska H, Stahl B, Guarner F, Respondek F, Whelan K, Coxam V, Davicco MJ, Leotoing L, Wittrant Y, Delzenne NM, Cani PD, Neyrinck AM, Meheust A. Prebiotics effects: metabolic and health benefits. Brit J Nutr 2010; 104: S1-S63.
7. FAO Technical Meeting on prebiotics. Food and Agriculture Organization of the United Nations (FAO). Food Quality and Standards Service (AGNS). September 15-16, 2007.
8. ISAPP (2008) 6th Meeting of the International Scientific Association of Probiotics and Prebiotics, London, Ontario.
9. World Gastroenterology Organisation (WGO) (2011). En: Guia Practica de la Organizacion Mundial de Gastroenterologia: Probioticos y prebioticos (http://www.worldgastroenterology.org). 2011.
10. Gibson GR, Ottaway PB, Rastall RA. Prebiotics. New developments in functional foods. ISBN 1-902423-43-7, Chadwick House Group Limited 2000, 1-108.
11. Gibson GR, Scott KP, Rastall RA, Tuohy KM, Hotchkiss A, Dubert-Ferrandon A, Gareau M, Murphy EF, Saulnier D, Loh G, Macfarlane S, Delzenne N, Ringel Y, Kozianowski G, Dickman R, Lenoir-Wijnkoop I, Wlaker C, Buddington R. Dietary prebiotics: current status and new definition. Food Sci Technol Bull 2010; 7: 1-19.
12. Rastall RA. Functional oligosaccharides: application and manufacture. Annu Rev Food Sci Technol 2010; 1: 305-339.
13. Van de Wiele T, Boon N, Possemiers S, Jacobs H, Verstraete W. Inulin-type fructans of longer degree of polymerization exert more pronounced in vitro prebiotic effects. J Appl Microbiol 2006; 102: 452-460.
14. Macfarlane GT, Steed H, Macfarlane S. Bacterial metabolism and health-related effects of galacto-oligosaccharides and other prebiotics. J Appl Microbiol 2008; 104: 305-344.
15. Rodriguez-Colinas B. Obtencion enzimatica, caracterizacion y propiedades prebioticas de oligosacaridos empleados en leches infantiles. Tesis Doctoral Noviembre 2013.
16. Birkett AM, Francis CC. Short-Chain Fructo-Oligosaccharide. A Low Molecular Weight Fructan. En: Handbook of prebiotics and probiotics ingredients. Health benefits and food applications (eds S.S. Cho & E.T. Finocchiaro) CRC Press Taylor & Francis Group Boca Raton New York , 2010 Capitulo 2, pp 13-42. ISBN-10: 1-4200-6213-1; ISBN-13: 978-1-4200-6213-7.
17. Villamiel M, Montilla A, Olano A, Corzo N “Production and bioactivity of oligosaccharides derived from lactose”. En: Food Oligosaccharides: Production, Analysis and Bioactivity. ISBN: 978-1-118-42649-4.Eds F., Javier Moreno y M. Luz Sanz. Wiley-Blackwell, Chichester, United Kingdom. pp.137-167 (2014).
18. Petuely F. Lactobacillus bifidus flora produced in artificially-fed infants by bifidogenic substances (bifidus factor). Z Kinderheilkd 1957; 79: 174-179.
19. Adachi S, Patton S. Presence and significance of lactulose in milk products: A review. J Dairy Sci 1961; 44: 1375-1393.
20. Olano A, Corzo N. Lactulose as a food ingredient. J Sci Food Agric 2009; 89: 1987-1990.
21. Schuster-Wolff-Buhring R, Fischer L, Hinrichs J. (2010) Production and physiological action of the disaccharide lactulose. Int Dairy J 2010; 20: 731-741.
22. Panesar PS, Kumari S. Lactulose: Production, purification and potential applications. Biotechnol Adv 2011; 29: 940-948.
23. Cardelle-Cobas A, Martinez-Villaluenga C, Villamiel M, Olano A, Corzo N. Synthesis of oligosaccharides derived from lactulose and Pectinex Ultra SP-L. J Agric Food Chem 2008; 56: 3328-3333.
24. Martinez-Villaluenga C, Cardelle-Cobas A, Olano A, Corzo N, Villamiel M, Jimeno, ML. Enzymatic synthesis and identification of two trisaccharides produced from lactulose by transgalactosylation. J Agric Food Chem 2008; 56: 557-563.
25. Cardelle-Cobas A, Fernandez M, Salazar N, Martinez-Villaluenga C, Villamiel M, Ruas-Madiedo P, de los Reyes-Gavilan C. Bifidogenic effect and stimulation of short chain fatty acid production in human faecal slurry cultures by oligosaccharides derived from lactose and lactulose. J Dairy Res 2009; 76: 317-325.
26. Cardelle-Cobas A, Corzo N, Olano A, Pelaez, C, Requena T, Avila M. (2011b) Galactooligosaccharides derived from lactose and lactulose: influence of structure on Lactobacillus, Streptococcus, and Bifidobacterium growth. Int J Food Microbiol 2011; 149: 81-87.
27. Cardelle-Cobas A, Olano A, Corzo N, Villamiel M, Collins M, Kolida S, Rastall, RA (2012) In vitro fermentation of lactulose-derived oligosaccharides by mixed fecal microbiota. J Agric Food Chem 2012; 60: 2024-2032.
28. Marin-Manzano MC, Abecia L, Hernndez-Hernndez O, Sanz ML, Montilla A, Olano A, Rubio LA, Moreno FJ, Clemente A. Galacto-oligosaccharides derived from lactulose exert a selective stimulation on the growth of Bifidobacterium animalis in the large intestine of growing rats. J Agric Food Chem 2013; 61: 7560-7567.
29. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), 2010. Scientific opinion on the substantiation of health claims related to lactulose and decreasing potentially pathogenic gastro-intestinal microorganisms (ID 806) and reduction in intestinal transit time (ID 807) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal 8, 1806-1821.
30. Playne MJ, Crittenden RG (2009) Galacto-oligosaccharides and Other Products Derived from Lactose. In: Advanced Dairy Chemistry, Volume 3, Lactose, Water, Salts and Minor Constituents. (eds, P.L.H. McSweeney & P.F. Fox), pp. 121-201. Espringer, New York.
31. Miller JN, Whistler RL. 2000. Carbohydrates. In O. Fennema (ED). Food Chemistry (pp207) New York: Marcel Dekker.
32. Boon MA, Janssen AEM, Van’t Riet K. Effect of temperature and enzyme origin on the enzymatic synthesis of oligosaccharides. Enzyme Microb Technol 2000; 26: 271-281.
33. Splechtna B, Nguyen TH, Steinbock M, Kulbe KD, Lorenz W, Haltrich D. Production of prebiotic galacto-oligosaccharides from lactose using -galactosidases from Lactobacillus reuteri. J Agric Food Chem 2006; 54: 4999-5006.
34. Tzortzis G, Vulevic J. Galactooligosaccharide prebiotics, In: Prebiotics and Probiotics: Science and Technology (eds D. Charalampopoulos & R.A. Rastall), Springer Science, New York, 2009, pp. 207-244.
35. Gaur R, Pant H, Jain R, Khare SK. Galacto-oligosaccharide synthesis by immobilized Aspergillus oryzae beta-galactosidase. Food Chem 2006; 97:426-430.
36. Sears P, Wong CH. Toward automated synthesis of oligosaccharides and glycoproteins, Science 2001; 291: 2344-2350.
37. Padilla B, Ruiz-Matute A.I, Belloch C, Cardelle-Cobas A, Corzo N, Manzanares, P. Evaluation of oligosaccharide synthesis from lactose and lactulose using β-galactosidases from Kluyveromyces aisolated from artisanal cheeses. J Agric Food Chem 2012; 60: 5134-5141.
38. Rodriguez-Colinas B, Poveda A, Jimenez-Barbero J, Ballesteros AO, Plou FJ (2012) Galacto-oligosaccharide synthesis from lactose solution or skim milk using the β-galactosidase from Bacillus circulans. J Agric Food Chem 2012; 60: 6391-6398.
39. Torres D, Goncalves M, Teixeira J, Rodrigues L. (2010) Galacto-oligosaccharides: production, properties, applications, and significance as prebiotics. Compr Rev Food Sci Food Saf 2010; 9: 438-454.
40. Sangwan V, Tomar SK, Singh RRB, Singh AK, Ali, B. (2011) Galactooligosaccharides: novel components of designer foods. J Food Sci 2011; 76: R103-R111.
41. Ito M, Deguchi Y, Miyamori A, Matsumoto K, Kikuchi H, Matsumoto K, Kobayashi Y, Yajima T, Kan T. Effects of administration of galactooligosaccharides on the human faecal microflora, stool weight and abdominal sensation. Microb Ecol Health Dis 1990; 3: 285-292.
42. Otieno DO. Synthesis of β-galactooligosaccharides from lactose using microbial β-galactosidases. Compr Rev Food Sci Food Saf 2010; 9: 471-482.
43. Bode L. Recent advances on structure, metabolism, and function of human milk oligosaccharides J Nutr 2006; 136 (8):2127-30.
44. Venema K. Intestinal fermentation of lactose and prebiotic lactose derivatives, including human milk oligosaccharides. Int Dairy J 2012; 22: 123-140.
45. Barile D, Rastall RA. Human milk and related oligosaccharides as prebiotics. Curr Opin Biotechno 2013; 24: 214-219.
46. Kunz C, Kuntz S, Rudloff S. “Bioactivity of human milk oligosaccharides“. En: Food Oligosaccharides: Production, Analysis and Bioactivity. ISBN: 978-1-118-42649-4. Eds F. Javier Moreno y M. Luz Sanz. Wiley-Blackwell, Chichester, United Kingdom. pp. 5-20, 2014.
47. Morrow AL, Ruiz-Palacios GM, Jiang X, Newburg DS. Human-milk glycans that inhibit pathogen binding protect breast-feeding infants against infectious diarrhea”. J Nutr 2005; 135: 1304-1307.
48. Makelainen H, Forssten S, Saarinen M, Stowell J, Rautonen N, Ouwehand AC. Xylo-oligosaccharides enhance the growth of bifidobacteria and Bifidobacterium lactis in a simulated colon model. Beneficial Microbes 2010; 1: 81-91.
49. Muralikrishna G, Schwarz S, Dobleit G, Fuhrmann H, Krueger M. Fermentation of feruloyl and non-feruloyl xylooligosaccharides by mixed fecal cultures of human and cow: a comparative study in vitro Eur Food Res Technol 2011; 232: 601-61.
50. Van Craeyveld V, Swennen K, Dornez E, Van de Wiele T, Marzorati M, Verstraete W, Delaedt Y, Onagbesan O, Decuypere E, Buyse J, De Ketelaere B, Broekaert WF, Delcour JA, Courtin Ch M. Structurally different wheat-derived arabinoxylooligosaccharides have different prebiotic and fermentation properties in rats J Nutr, 2008; 138: 2348-2355.
51. Chung Y, Hsu, C, Ko C, Chan Y. Dietary intake of xylooligosaccharides improves the intestinal microbiota, fecal Moisture, and pH Value in the elderly, Nutr Res 2007; 27: 756-761.
52. Lecerf JM, Depeint F, Clerc E, Dugenet Y, Niamba CN, Rhazi L, Cayzeele A, Abdelnour G, Jaruga A, Younes H, Jacobs H, Lambrey G, Abdelnour AM, Pouillart PR. Xylo-oligosaccharide (XOS) in combination with inulin modulates both the intestinal environment and immune status in healthy subjects, while XOS alone only shows prebiotic properties. Br J Nutr 2012; 108: 1847-1858.
53. Francois IEJA, Lescroart O, Veraverbeke WS, Marzorati M, Possemiers S, Evenepoel P, Hamer H, Houben E, Windey K, Welling GW, Delcour JA, Cour tin Ch M, Verbeke, K, Broekaert WF. Effects of a wheat bran extract containing arabinoxylan oligosaccharides on gastrointestinal health parameters in healthy adult human volunteers: a double-blind, randomised, placebo-controlled, cross-over trial. Br J Nutr 2012;, 108: 2229-2242.
54. Sheu WHH, Lee IT, Chen W, Chan YC. Effects of xylooligosaccharides in type 2 diabetes mellitus. J Nutr Sci Vitaminol 2008; 54: 396-401.
55. Moure A, Gullon P, Dominguez H Parajo JC. Advances in the manufacture, purification and applications of xylo-oligosaccharides as food additives and nutraceuticals. Process Biochem 2006; 41: 1913-1923.
56. Chen HH, Chen YK, Chang HC, Lin SY. Immunomodulatory effects of xylooligosaccharides. Food Sci Techol Res 2012; 18(2): 195-199.
57. Terada A, Hara H, Kato S, Kimura T, Fujimori I, Hara K, Maruyama T, Mitsuoka T. Effect of lactosucrose (4G-β-D-galactosylsucrose) on fecal flora and fecal putrefactive products of cats. J Vet Med Sci 1993; 55: 291-295.
58. Terada A, Hara H, Kato S, Kimura T, Fujimori I, Hara K, Maruyama T, Mitsuoka T. Effect of lactosucrose (4G-β-D-galactosylsucrose) on fecal flora and fecal putrefactive products of cats. J Vet Med Sci 1993; 55: 291-295.
59. Terada A, Hara H, Sakamoto J, Sato N, Takagi S, Mitsuoka T, Mino R, Hara, K, Fujimori I, Yamada T. Effects of dietary supplementation with lactosucrose (4G-β-D-galactosylsucrose) on cecal flora, cecal metabolites, and performance in broiler-chickens. Poult Sci 1994; 73: 1663-1672.
60. Ohkusa T, Ozaki Y, Sato C, Mikuni K, Ikeda H. (1995) Longterm ingestion of lactosucrose increases Bifidobacterium sp. in human fecal flora. Digestion 1995; 56: 415-420.
61. Takei K, Akakura K, Ueda T, Mikami, K, Haruo I. Effect of oral lactosucrose supplementation on human enteric oxalate-degrading bacteria. Hinyokika kiyo. Acta Urologica Japonica 2006; 52: 687-691.
62. Monsan P, Ouarne F. Oligosaccharides derived from sucrose. In: Prebiotics and Probiotics, Science and Technology, Eds. D. Charalampopoulus and R. A. Rastall, Springer. Science New York Ch 10 pp 293-336, 2009.
63. Kaneko T, Yokoyama A, Suzuki M. Digestibility characteristics of isomalto-oligosaccharides in comparison with several saccharides using the rat jejunum loop method. Biosci Biotechnol Biochem 1995; 9: 1190-1194.
64. Rycroft C E, Jones M E, Gibson G R, Rastall R A A comparative in vitro evaluation of the fermentation properties of prebiotic oligosaccharides. J. Appl. Microbiol. 2001; 91: 879-887.
65. Makelainen H, Hasselwander O, Rautonen N, Ouwehand AC. Panose, a new prebiotic candidate. Lett Appl Microbiol 2009; 49: 666-672.
66. Ketabi A, Dieleman LA, Ganzle MG. Influence of isomalto-oligosaccharides on intestinal microbiota in rats. J Appl Microbiol 2011; 110: 1297-1306.
67. Hu Y, Ketabi A, Buchko A, Ganzle MG. Metabolism of isomalto-oligosaccharides by Lactobacillus reuteri and bifidobacteria. Lett Appl Microbiol 2013; 57: 108-114.
68. Gu Q, Yang Y, Jiang G, Chang G. Study on the regulative effect of somaltooligosaccharides on human intestinal flora]. Wei Sheng Yan Jiu 2003; 32: 54-55.
69. Zhang F, Li DF, Lu WQ. and Yi, G.F. Effects of isomalto-oligosaccharides on broiler performance and intestinal microflora. Poult Sci 2003; 82: 657-663.
70. Thitaram SN, Chung CH, Day DF, Hinton A, Bailey JS, Siragusa GR Isomaltooligosaccharide increases cecal bifidobacterium population in young broiler chickens. Poult Sci 2005; 84: 998-1003.
71. Rehman H, Vahjen W, Kohl-Parisini A, Ijaz A, Zentek J. Influence of fermentable carbohydrates on the intestinal bacteria and enteropathogens in broilers. Worlds Poult Sci J 2009; 65: 75-90.
72. Chen HL, Lu YH, Lin JJ, Ko LY. Effects of isomalto-oligosaccharides on bowel functions and indicators of nutritional status in constipated elderly men. J Am Coll Nutr 2001; 20: 44-49.
73. Yen CH, Tseng YH, Kuo YW, Lee MC, Chen HL. Long-term supplementation of isomalto-oligosaccharides improved colonic microflora profile, bowel function, and blood cholesterol levels in constipated elderly people-a placebo-controlled, diet-controlled trial. Nutrition 2011; 17: 445-450.
74. Wang HF, Lim P-S, Kao MD, Chan EC, Lin LC, Wang NP. Use of isomalto-oligosaccharide in the treatment of lipid profiles and constipation in hemodialysis patients. J Renal Nutr 2001; 11: 73-79.
75. Watanabe T, Watanabe M, Kageyama, S. Prophylactic or ameliorating agent for immunological dysfunction, Prophylactic or ameliorating agent for microbism, tumor immunological enhancer and Prophylacticor ameliorating agent for in vivo various dysfunctions and functional food comprising α(1→6)-bonded chain glucose oligomer as active ingredient. Japanese Patent, JP 2002161039 (2002).
76. Espinosa-Martos I, Ruperez P. Soybean oligosaccharides. Potential as new ingredients in functional foods. Nutr Hosp 2006; 21: 92-96.
77. Hayakawa K, Mizutani J, Wad K, Masai T, Yoshihara I, Mitsuoka T. Effects os soybean oligosaccharides on human fecal microflora. Microb Ecol Health Dis 1990; 3: 293-303.
78. Crittenden R. Emerging Prebiotic Carbohydrates. En: Prebiotics. Development & Application. Gibson, G.R. & Rastall, R.A. (Eds). John Wiley & Sons, Ltd. Chichester. England, 2006 pp 111-33.
79. Leach JD, Rastall RA, Gibson GR. Prebiotics: Past, Present and Future. En: Prebiotics. Development & Application. Gibson, G.R. & Rastall, R.A. (Eds). John Wiley & Sons, Ltd. Chichester. England, 2006.
80. Chen H, Liu LJ, Zhu JJ, Xu B, Li R. Effects of soybean oligosaccharides on blood lipid, glucose levels and antioxidant enzymes activity in high fat rats. Food Chem 2010; 119: 1633-1636.
81. Valette JP, Franquet B, Wolter R. Calcul de la ration du cheval trotteur (Calculation of the daily ration of the horsetrotter). Equathlon 1993; 5: 8-9.
82. Chung CH, Day DF. Glucooligosaccharides fromLeuconostocmesenteroides B-742 (ATCC 13146): a potential prebiotic. J Indus Microbiol Biotechnol 2002; 29: 196-199.
83. Wichienchot S, Prasertsan P, Hongpattarakere T, Gibson GR, Rastall RA. In vitro Fermentation of Mixed Linkage Glucooligosaccharides Produced by Gluconobacteroxydans NCIMB 4943 by the Human Colonic Microflora. Curr Issues Intestinal Microbiol 2006; 7: 7-12.
84. Wichienchot S, Prasertsan P, Hongpattarakere T, Gibson GR, Rastall RA. In vitro Three-stage Continuous Fermentation of Gluco-oligosaccharides Produced by Gluconobacteroxydans NCIMB 4943 by the Human Colonic Microflora. Curr Issues Intestinal Microbiol 2006; 7: 13-18.
85. Sarbini SR, Kolida S, Gibson GR, Rastall RA. In vitro fermentation of commercial -gluco-oligosaccharide by faecal microbiota from lean and obese human subjects. Bri J Nutr 2013; 109: 1980-1989.
86. Gulfi M, Arrigoni E, Amado R. The chemical characteristics of apple pectin influence its fermentability in vitro. LWT-Food Sci Technol 2006; 39: 1001-1004.
87. Gullon B, Gomez, B, Martinez-Sabajanes M, Yanez R, Parajo JC. Pectic oligosaccharides: Manufacture and functional properties. Trends Food Sci Technol 2013; 30: 153-161.
88. Van Laere KMJ, Hartemink R, Bosveld M, Schols HA Voragen AG. Fermentation of plant cell wall derived polysaccharides and their corresponding oligosaccharides by intestinal Bacteria. J Agric Food Chem 2000; 48: 1644-52.
89. Suzuki Y, Tanaka K, Amano T, Asakura T, Muramatsu, N. Utilization by intestinal bacteria and digestibility of arabino-oliogsaccharides in vitro. J Japan Soc Hort Sci 2004; 73: 574-79.
90. Onumpai C, Kolida S, Bonnin E, Rastall RA. Microbial utilization and selectivity of pectin fractions with various structures. Appl Environ Microbiol 2011; 77: 5747-5754.
91. Magne F, Hachelaf W, Suau A, Boudraa G, Bouziane-Nedjadi K, Rigottier-Gois L, Touhami M, Desjeux JF, Pochart P. Effects on faecal microbiota of dietary and acidic oligosaccharides in children during partial formula feeding. J Pediatr Gastroenterol Nutr 2008; 46: 580-588.
92. Westerbeek EAM, Slump RA, Lafeber HN, Knol J, Georgi G, Fetter WPF, van Elburg RM. The effect of enteral supplementation of specific neutral and acidic oligosaccharides on the faecal microbiota and intestinal microenvironment in preterm infants. Eur J Clin Microbiol Infect Dis 2013; 32: 269-276.
93. Gori A, Rizzardini G, van’t Land B, Amor KB, van Schaik J, Torti C, Quirino T, Tincati C, Bandera, A Knol J, Benlhassan-Chahour K, Trabattoni D, Bray D, Vriesema A, Welling G, Garssen J, Clerici M. Specific prebiotics modulate gut microbiota and immune activation in HAART-naive HIV-infected adults: results of the “ COPA ” pilot randomized trial. Mucosal Immunol 2011; 4: 554-563.
94. Makivuokko H, Nurmi J, Nurminen P, Stowell J, Rautonen N. In vitro effects on polydextose by colonic bacteria and Caco-2cell cyclooxygenase gene expression, 2005 Nutrition Cancer, 2005; 52: 94-104.
95. Beards E, Tuohy K, Gibson G. A Human volunteer study to assess the impact of confectionery sweeteners on the gut microbiota composition. Br J Nutr 2010; 104: 701-708.
96. Costabile A; Fava F; Roytio H. Forssten SD, Olli K, Klievink J, Rowland IR, Ouwehand AC, Rastall RA, Gibson GR, Walton GE(2012). Impact of polydextrose on the faecal microbiota: a double-blind, crossover, placebo-controlled feeding study in healthy human subjects. Brit J Nutr 2012; 108: 471-481.
97. Ashley C, Johnston W H, Harris Ch L, Stolz S I, Wampler, J L, Berseth C L. Growth and tolerance of infants fed formula supplemented with polydextrose (PDX) and/or galactooligosaccharides (GOS): double-blind, randomized, controlled trial. Nutr J 2012; 11:1-10.
98. Ribeiro T C M, Costa-Ribeiro H Jr, Almeida PS, Pontes MV, Leite MEQ, Filadelfo LR, Khoury J C, Bean JA, Mitmesser SH, Vanderhoof JA, Scalabrin DMF. Stool pattern changes in toddlers consuming a follow-on formula supplemented with polydextrose and galactooligosaccharides. J Pedr Gastroenterol Nutr 2012; 54: 288-290.
99. Scalabrin DMF, Mitmesser SH, Welling GW, Harris, CL, Marunycz JD, Walker DC, Bos NA, Tolkko S, Salminen, S, Vanderhoof, JA New prebiotic blend of polydextrose and galacto-oligosaccharides has a bifidogenic effect in young infants. J Pediatr Gastroenterol Nutr 2012, 54: 343-352.
100. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), 2011. Scientific Opinion on the substantiation of health claims related to polydextrose and changes in bowel function (ID 784), changes in short chain fatty acid (SCFA) production and/or pH in the gastro-intestinal tract (ID 784), decreasing potentially pathogenic gastro-intestinal microorganisms (ID 785) and reduction of gastro-intestinal discomfort (ID 784) pursuant to Article 13(1) of Regulation (EC) No 1924/20061. EFSA Journal. 2011, 9(6), 2256.
101. Nikolic M, Lopez P, Strahinic I, Suarez A, Kojic M, Fernandez-Garcia M, Topisirovic L, Golic N, Ruas-Madiedo P. Characterisation of the exopolysaccharide (EPS)-producing Lactobacillus paraplantarum BGCG11 and its non-EPS producing derivative strains as potential probiotics. Int J Food Microbiol 2012 ; 17: 158:155-62.
102. O’Sullivan L, Murphy B, McLoughlin P, Duggan P, Lawlor PG, Hughes H, Gardiner GE. Prebiotics from marine macroalgae for human and animal health applications. Marine Drugs 2010; 8: 2038-2064.
103. Gupta S, Abu-Ghannam N. Bioactive potential and possible health effects of edible brown seaweeds (Review). Trends Food Sci Technol 2011; 22: 315-326.
104. Ruperez P, Gomez-Ordonez E, Jimenez-Escrig A. Biological activity of algal sulfated and non-sulfated polysaccharides. In: Bioactive Compounds from Marine Foods: Plant and Animal Sources. Hernandez-Ledesma B. and Herrero M. (Eds), Wiley-Blackwell’s Food Science and Technology book, 2013, pp. 219-248, ISBN: 978-1-118-41284-8.
105. Lahaye M, Robic A. Structure and function properties of ulvan, a polysaccharide from green seaweeds. Biomacromolecules 2007; 6: 1765-1774.
106. Gomez-Ordonez E, Jimenez-Escrig A, Ruperez P. Effect of the red seaweed Mastocarpus stellatus intake on lipid metabolism and antioxidant status in healthy Wistar rats. Food Chem 2012; 135: 806-811.
107. Jimenez-Escrig A, Gomez-Ordonez E, Tenorio MD, Ruperez P. Antioxidant and prebiotic effects of dietary fiber co-travelers from sugar Kombu in healthy rats. J Appl Phycol 2013; 25: 503-512.
108. Sanz ML, Ruiz-Matute AI, Corzo N, Martinez-Castro I. Analysis of prebiotic oligosaccharides. In: Prebiotics and Probiotics Science and Technology (eds D. Charalampopoulos & R.A. Rastall), Springer Science, New York, 2009, Ch 13, pp. 465-534.
109. Brummer Y, Cui SW. Understanding carbohydrate analysis. In: Cui, S.W. (Ed) Food Carbohydrates: Chemistry, Physical Properties, and Applications. CRC Press: West Palm Beach, 2005.
110. Hernandez-Hernandez O., I. Calvillo, R. Lebron-Aguilar, F.J. Moreno, M.L. Sanz Hydrophilic Interaction Liquid Chromatographic (HILIC) coupled to mass spectrometry for the characterization of prebiotic galactoligosaccharides. J Chromatogr A 2012; 1220: 57-67.
111. Sanz M.L., J. Sanz, I. Martinez-Castro. Characterization of O-Trimethylsilyl oximes of disaccharides by gas chromatography-mass spectrometry. Chromatographia 2002; 56: 617-622.
112. Cardelle-Cobas A, Martinez-Villaluenga C, Sanz, ML, Montilla A. Gas chromatographic-mass spectrometric analysis of galactosyl derivatives obtained by the action of two different β-galactosidases. Food Chem 2009; 114: 1099-1105.
113. Marry M., D.M. Cavalier, J.K. Schnurr, J. Netland, Z.Y. Yang, V. Pezeshk, W.S. York, M. Pauly, A.R. White Structural characterization of chemically and enzymatically derived standard oligosaccharides isolated from partially purified tamarind xyloglucan. Carbohydr Polym 2003; 51: 347-356.
114. Avila-Fernandez A, Galicia-Lagunas N, Rodriguez-Alegria ME, Olvera C, Lopez Munguia A. Production of functional oligosaccharides through limited acid hydrolysis of agave fructans. Food Chem 2011; 129: 380-386.
115. Blanch M, Sanchez-Ballesta MT, Escribano MI, Merodio C Fructo-oligosaccharides in table grapes and response to storage. Food Chem 2011; 129: 724-730.
116. Mateos-Aparicio I, Redondo A, Villanueva MJ, Zapata-Revilla MA, Tenorio-Sanz MD. Pea pod, brad bean pod and okara, potential sources of functional compounds. LWT-Food Sci Technol 2010; 43: 1467-1470.
117. Alpert A.J. Hydrophilic-Interaction chromatography for the separation of peptides, nucleic-acids and other polar compounds. J Chromatogr 1990; 499: 177-196.
118. Zaia J. Mass spectrometry of oligosaccharides. Mass Spectrom Rev 2004; 23: 161-227.
119. Pasanen S, Janis J, Vainiotalo P. Cello-, malto-and xylooliogosaccharide fragmentation by collision-induced dissociation using QIT and FT-ICR mass spectrometry: a systematic study. Int J Mass Spectrom 2007; 263: 22-29.
120. Matamoros-Fernandez LE, Obel N, Scheller HV, Roepstorff P. Characterization of plant oligosaccharides by matrix assisted laser desorption/ionization and electrospray mass spectrometry. J Mass Spectrom 2003; 38: 427-37.
121. Dreisewerd K, Kolbl S, Peter-Katalinic J, Berkenkamp S, Pohlentz G. Analysis of native milk oligosaccharides directly from thin-layer chromatography plates by matrix-assisted laser desorption/ionization orthogonal-time-of-flight mass spectrometry with a glycerol matrix. J Am Soc Mass Spectrom 2006; 17: 139-150.
122. Kajihara Y, Sato H. Structural analysis of oligosaccharides by nuclear magnetic resonance method. Trends Glycosci Glycotechnol 2003; 15: 197-220.
123. Hernandez O, A.I. Ruiz-Matute AI, Olano A, Moreno FJ, Sanz ML. Comparison of fractionation techniques to obtain prebiotic galactooligosaccharides. Int Dairy J 2009; 19: 531-536.
124. Clemente A. In vivo assessment of the bioactivity of food oligosaccharides. In: “Food oligosaccharides: Production, Analysis and Bioactivity”. ISBN: 978-1-118-42649-4. Eds F. Javier Moreno y M. Luz Sanz., John Wiley & Sons, Ltd., Chichester, England Ch 14, pp. 238-252.
125. Gueimonde M, de los Reyes-Gavilan CG. Detection and enumeration of gastrointestinal microorganisms. En: “Handbook of probiotics and prebiotics”. Lee, YK, and Salminen S. (eds). John Wiley & Sons, Inc. (Ed.), Hoboken, New Jersey, USA. pp. 25-43, 2009.
126. Martin FP, Collino S, Rezzi S, Kochhar S. Metabolomics applications to decipher gut microbial metabolic influence in health and disease. Front Physiol 2012; 3: 1-11.
127. Van den Abbeele P, Grootaert C, Marzorati M, Possemiers S, Verstraete W, Gerard P, Rabot S, Bruneau A, El Aidy S, Derrien M, Zoetendal E, Kleerebezem M, Smidt H, Van de Wiele T. (2010). Microbial community development in a dynamic gut model is reproducible, colon region specific, and selective for Bacteroidetes and Clostridium cluster IX. Appl Enviro Microbiol 2010; 76: 5237-5246.
128. Marzorati M, Van Den Abbeele P, Possemiers S, Benner J, Verstraete W, Van De Wiele T. Studying the host-microbiota interaction in the human gastrointestinal tract: basic concepts and in vitro approaches. Ann Microbiol 2011; 61: 709-715.
129. Tabernero M, Venema K, Maathuis AJH, Saura-Calixto FD. Metabolite production during in vitro colonic fermentation of dietary fiber: analysis and comparison of two European diets. J Agric Food Chem 2011; 59: 8968-8975.
130. Cencič A, Langerholc T. Functional cell models of the gut and their application in Food microbiology-A review. Int J Food Microbiol 2010; 141:S4-S14.
131. Van den Abbeele P, Roos S, Eeckhaut V, MacKenzie DA, Derde M, Verstraete W, Marzorati M, Possemiers S, Vanhoecke B, van Immerseel F, van de Wiele T. Incorporating a mucosal environment in a dynamic gut model results in a more representative colonization by lactobacilli. Microb Biotechnol 2012; 5: 106-115.
132. Yu J, Peng S, Luo D, March JC. In vitro 3D human small intestinal villous model for drug permeability determination. Biotechnol Bioeng 2012; 109: 2173-2178.
133. Parnell JA, Reimer RA. Prebiotics fibres dose-dependently increase satiety hormones and alter Bacteroidetes and Firmicutes in lean and obese JCR:LA-cp rats. Br J Nutr 2012; 107: 601-613.
134. Guarner F, Azpiroz F. La evaluacion cientifica de los alimentos funcionales. En: Juarez M, Olano A, Morais F, eds. Alimentos Funcionales. Madrid: FECYT, 2005: 11-22.
135. Azpiroz F. From sensation to perception: the gut brain connection. En: Pasricha J, Willis WD, Gebhart GF. Chronic Abdominal and Visceral Pain. Theory and Practice. Boca Raton FL: CRC Press, 2007: 193-203.
136. Mussato SL, Mancilha IM. Non-digestible oligosaccharide: a review. Carbohydr Polym 2007; 68: 587-507.
137. Caselato de Sousa VM, Freitas dos Santos E, Sgarbieri VC The importance of prebiotics in functional foods and clinical practice. Food Nutr Sci 2011; 2: 133-144.
138. Steed H, Macfarlane, S. Mechanisms of prebiotic impact on health. En: Charalampopoulos, D., Rastall, R. A., (Eds.), En: Prebiotics and Probiotics: Science and Technology (eds D. Charalampopoulos & R.A. Rastall), Springer Science, New York, 2009, pp. 135-161.
139. Aziz Q, Dore J, Emmanuel A, Guarner F, Quigley EMM. Gut microbiota and gastrointestinal health: current concepts and future directions. Neurogastroenterol Motil 2013; 25: 4-15.
140. Corzo N, Montilla A, Cardelle-Cobas A, Olano A. “Carbohidratos prebioticos derivados de la lactosa”. En: Funcionalidad de componentes lacteos. Capitulo 8, pp 159-178. Proyecto CYTED: N° XI.24. Ed. Universidad Miguel Hernandez, 2009.
141. Bornet FRJ, Brouns F. Immune-stimulating and gut health-promoting properties of short-chain fructo-oligosaccharides. Nutr Rev 2002; 60: 326-334.
142. Maning TS, Gibson, GR. Prebiotics. Best Pract Res Clin Gastroenterol 2004; 18: 287-298.
143. Martin R, Nauta AJ, Ben Amor K, Knippels LMJ, Knol J, Garssen J. Early life: gut microbiota and immune development in infancy. Beneficial Microbes 2010; 1: 367-382.
144. Kajihara M, Kato S, Konishi M, Yamagishi Y, Horie Y, Ishii H. Xylooligosaccharide decreases blood ammonia levels in patients with liver cirrhosis. Am J Gastroenterol 2000; 95:2514.
145. Szilagyi A. Functional Disaccharides: Lactulose, Lactitol, and Lactose. En<. Handbook of prebiotics and probiotics ingredients. Health benefits and food applications (eds S.S. Cho & E.T. Finocchiaro) CRC Press Taylor & Francis Group Boca Raton New York , 2010 Capitulo 5, pp 95-122. ISBN-10: 1-4200-6213-1; ISBN-13: 978-1-4200-6213-7.
146. Crittenden RG, Playne MJ. Production, properties and applications of food-grade oligosaccharides. Trends Food Sci Technol 1996; 7: 353-61.
147. Roberfroid M. Prebiotics: The concept revisited. J Nutr 2007; 137: 830S-837S.